Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ASTM-AASTROM BIOSCIENCES: STEM CELL RESEARCH -- Ignore unavailable to you. Want to Upgrade?

To: Probart who wrote (526)	1/29/1999 10:04:00 AM
From: Ron	Read Replies (1) \| Respond to of 1084

Thanks..I'll listen to it online www.audiohighway.com

To: Probart who wrote (526)	1/31/1999 1:23:00 AM
From: TheAlaskan	Read Replies (2) \| Respond to of 1084

Stem cell transplant..and your insurance co?? Desperate patients are starting to sue insurance carriers to force coverage. And why not, the results are clear and conclusive. Note that ASTM is conducting breast cancer Replicell studies at Loyola. cleveland.com:80/business/lnews/f30sue.phtml On another note...ASTM should be releasing PR on European launch soon. They are building units (subcontractors-SEAMed & others) and getting the pipeline filled. By the way- what was the essence of the NPR piece?? The Alaskan